Key result
CMR detects myocardial fibrosis in 70% of patients with Duchenne or Becker muscular dystrophies.
Why the study?
Cardiomyopathy is common in muscular dystrophies, but it was unclear whether cardiovascular magnetic resonance could detect and quantify early-stage myocardial damage.
Can cardiovascular magnetic resonance detect myocardial fibrosis in patients with muscular dystrophy?
Observational (n=10)
Can cardiovascular magnetic resonance detect myocardial fibrosis in patients with muscular dystrophy?
CMR can identify myocardial fibrosis in patients with Duchenne or Becker muscular dystrophy, which correlates with reduced ejection fraction.
Answers are grounded in this paper and cite their sources.
May support earlier fibrosis detection by CMR in muscular dystrophy; hypothesis-generating and should not yet change practice.
OBJECTIVES: This study sought to analyze whether cardiovascular magnetic resonance (CMR) can detect and quantify myocardial damage in the early stages of cardiomyopathy in muscular dystrophies (MD). BACKGROUND: Muscular dystrophy is a genetic disease that involves skeletal and cardiac tissues of humans. Cardiomyopathy is common, and death secondary to cardiac or respiratory diseases occurs early in life. Cardiovascular magnetic resonance is a reliable method for assessing global and regional cardiac function, allowing also for the detection of myocardial fibrosis (MF). METHODS: Ten patients with Duchenne or Becker dystrophies were studied by CMR. Physical examination, Chagas disease serological tests, electrocardiogram, chest radiograph, total creatine kinase, and Doppler echocardiogram were also obtained in all patients. RESULTS: Patients with MF had a lower ejection fraction than those without. Myocardial fibrosis (midwall and/or subepicardial) was observed in 7 of the 10 patients, and the lateral wall was the most commonly involved segment. There was moderate correlation between segmental MF and dysfunction. CONCLUSIONS: Cardiovascular magnetic resonance can identify MF and may be useful for detecting the early stages of cardiomyopathy in MD. Future work will be needed to evaluate whether CMR can influence cardiomyopathy and outcomes.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2007) conducted an observational in Muscular dystrophy (n=10). Cardiovascular magnetic resonance was evaluated on Detection of myocardial fibrosis. Cardiovascular magnetic resonance detected myocardial fibrosis in 70% (7 of 10) of patients with Duchenne or Becker muscular dystrophies.
Synapse has enriched 10 related papers. Consider them for comparative context: